We evaluated a reverse hybridization method for the simultaneous detection of nine mutations that are associated with Gaucher disease.
Introduction
Gaucher disease (GD) is the most prevalent (approx. 1:50 000) recessively inherited lysosomal storage disease. The majority of cases of GD, particularly within certain ethnic groups, are associated with a few prevalent well-characterized mutations in the glucocerebrosidase A (GBA) gene. Published data suggest that ¢ve mutations [N370S (AI226G), L444P (T1448C), 84GG, IVS 2+1 and R463C (C1504T)] account for around 50 -70% of UK cases with type I disease. 1, 2 We currently detect these ¢ve mutations using a polymerase chain reaction-restriction digestion method (PCR-RD) as a diagnostic aid for this condition. This is laborious as ¢ve di¡erent PCRs, restriction enzyme digestions and gel analyses are required. Here, we have evaluated a simpler, commercially available reverse hybridization (RH) method to detect these mutations, plus a further three point mutations [V394L (G1297T), D409H (G1342C) and R496H (G16064A)] and a common recombination mutation with the nearby pseudo-allele (RecNcil) in a cohort of 91 patients with GD.
Patients
Ninety-one consecutive patients from the Addenbrooke's Hospital National Centre for GD provided an EDTA blood sample as part of routine follow-up. All patients were clinically a¡ected with GD and had GBA enzyme activity below the local reference range at diagnosis. None of the patients described had type II GD, as de¢ned by severe progressive neurological deterioration within the ¢rst 2 years of life. All patients had been previously genotyped using the PCR-RD method.
Methods
DNAwas extracted from peripheral leucocytes using a conventional salting out method. 3 PCR-RD was performed as described previously. 4 RH was performed using a commercially available kit (Gaucher Disease StripAssay,ViennaLab Labordiagnostika GmbH,Vienna, Austria) on the same extracted DNA sample. Essentially all relevant GBA exons were ampli¢ed in a multiplex PCR using biotin-labelled primers. The labelled products were selectively hybridized to a test strip containing allele-speci¢c wild-type and mutant probes immobilized as parallel lines. Bound biotinylated sequences were detected using a streptavidin-alkaline phosphatase conjugate and colour substrates. The operator was blinded to the PCR-RD results.
Results
Results concurred where they could be obtained by both methods. The distribution of genotypes is shown in Fig. 1 . Both methods were susceptible to poorquality PCR templates. Repeat DNA extractions from a Short Report second blood sample worked by both methods, but these were excluded from the analysis. The multiplex RH method was marginally more robust than the RD-PCR (10 failed allele calls rather than 14). As RH was able to detect four more disease-causing mutations, we were able to detect four more alleles and thus fully characterize three more patients.
Discussion
The advantages of the RH assay are twofold. First, the method consists of a robust multiplex PCR. This could conceivably be incorporated into the PCR-RD method, but this would require considerable optimization of PCR and digestion conditions. The second advantage is the detection system, which uses enzyme-linked colour detection and a small linear array of hybridization probes. This negates the need for size separation and staining as used in the PCR-RD method. Mutation detection in GD is plagued by recombination events with the pseudo-GBA allele. In particular, L444P and also D409H may occur by this mechanism rather than by point mutation. The RH method detects the most common recombination event (RecNcil), which is not detected by PCR-RD. This can prevent misclassi¢cation of patients as L444P homozygotes when they carry a recombined allele, which can severely a¡ect prognosis in these patients. The success rate of detecting disease-associated alleles using RH is similar to that reported in a large study of non-Jewish patients where 37% of alleles were not detected using assays for the N370S, L444P, IVS2+1and 84GG. 2 This limits the diagnostic use of screening for a limited number of mutations in GD. The major advantage of this method would be to pre-screen patients to identify common mutations before a more extensive blotting and sequencing strategy to detect rare mutations and recombinations. Whilst the RH method considerably simpli¢es detection of common alleles, the process still requires DNA extraction and PCR, so cannot be recommended for use outside a dedicated PCR laboratory. 
